跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
REVESTIVE teduglutide 5 mg powder for solution for injection vial with diluent pre-filled syringe - TGA Drug Approval Details
Approvals
/
TGA
/
REVESTIVE teduglutide 5 mg powder for solution for injection vial with diluent pre-filled syringe
Approved
STANDARD
REVESTIVE teduglutide 5 mg powder for solution for injection vial with diluent pre-filled syringe
Takeda Pharmaceuticals Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
da9acde0716447a4
Company
Takeda Pharmaceuticals Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
da9acde0716447a4
Product Name
REVESTIVE teduglutide 5 mg powder for solution for injection vial with diluent pre-filled syringe
Artg Id
274911
Artg Name
REVESTIVE teduglutide 5 mg powder for solution for injection vial with diluent pre-filled syringe
Sponsor
Takeda Pharmaceuticals Australia Pty Ltd
Company Detail Path
/organization/takeda-pharmaceuticals-australia-pty-ltd
Artg Date
2017-05-19
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/3340db014bd4cda35b02dc5e1edd556a.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/89d82c6c9c6a7bc4f1edbb5fb96258c3.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
da9acde0716447a4
Type
Standard
Back to TGA Approvals